BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 23252993)

  • 1. Association between chronic kidney disease detected using creatinine and cystatin C and death and cardiovascular events in elderly Mexican Americans: the Sacramento Area Latino Study on Aging.
    Peralta CA; Lee A; Odden MC; Lopez L; Zeki Al Hazzouri A; Neuhaus J; Haan MN
    J Am Geriatr Soc; 2013 Jan; 61(1):90-5. PubMed ID: 23252993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: A primary care cohort study.
    Shardlow A; McIntyre NJ; Fraser SDS; Roderick P; Raftery J; Fluck RJ; McIntyre CW; Taal MW
    PLoS Med; 2017 Oct; 14(10):e1002400. PubMed ID: 29016597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of a cystatin C gene variant with cystatin C levels, CKD, and risk of incident cardiovascular disease and mortality.
    O'Seaghdha CM; Tin A; Yang Q; Katz R; Liu Y; Harris T; Astor B; Coresh J; Fox CS; Kao WH; Shlipak MG
    Am J Kidney Dis; 2014 Jan; 63(1):16-22. PubMed ID: 23932088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible risk of overestimation of renal function using cystatin C-based eGFR in testicular cancer survivors treated with cisplatin-based chemotherapy.
    Ichioka D; Kawai K; Tanaka K; Ishitsuka R; Yoshino T; Kimura T; Kandori S; Kawahara T; Kojima T; Usui J; Yamagata K; Miyazaki J; Nishiyama H
    Clin Exp Nephrol; 2018 Jun; 22(3):727-734. PubMed ID: 28948387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Difference Between Cystatin C- and Creatinine-Based Estimated GFR and Associations With Frailty and Adverse Outcomes: A Cohort Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
    Potok OA; Ix JH; Shlipak MG; Katz R; Hawfield AT; Rocco MV; Ambrosius WT; Cho ME; Pajewski NM; Rastogi A; Rifkin DE
    Am J Kidney Dis; 2020 Dec; 76(6):765-774. PubMed ID: 32682697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystatin C as a predictor of mortality in elderly patients with chronic kidney disease.
    Bevc S; Hojs N; Knehtl M; Ekart R; Hojs R
    Aging Male; 2019 Mar; 22(1):62-67. PubMed ID: 29912597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystatin C- and creatinine-based estimated glomerular filtration rate, vascular disease, and mortality in persons with diabetes in the U.S.
    Tsai CW; Grams ME; Inker LA; Coresh J; Selvin E
    Diabetes Care; 2014 Apr; 37(4):1002-8. PubMed ID: 24271191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation incorporating both cystatin C and creatinine best predicts individual risk: a cohort study in 444 patients with chronic kidney disease.
    Rogacev KS; Pickering JW; Seiler S; Zawada AM; Emrich I; Fliser D; Heine GH
    Nephrol Dial Transplant; 2014 Feb; 29(2):348-55. PubMed ID: 24166454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers of kidney function and prediction of death from cardiovascular and other causes in the elderly: A 9-year follow-up study.
    Salminen M; Laine K; Korhonen P; Wasen E; Vahlberg T; Isoaho R; Kivelä SL; Löppönen M; Irjala K
    Eur J Intern Med; 2016 Sep; 33():98-101. PubMed ID: 27370901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality.
    Peralta CA; Shlipak MG; Judd S; Cushman M; McClellan W; Zakai NA; Safford MM; Zhang X; Muntner P; Warnock D
    JAMA; 2011 Apr; 305(15):1545-52. PubMed ID: 21482744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Creatinine- versus cystatin C-based renal function assessment in the Northern Manhattan Study.
    Husain SA; Willey JZ; Park Moon Y; Elkind MSV; Sacco RL; Wolf M; Cheung K; Wright CB; Mohan S
    PLoS One; 2018; 13(11):e0206839. PubMed ID: 30427947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical Importance of GFR-Estimating Equations (eGFRcreat and eGFRcys)].
    Horio M
    Rinsho Byori; 2015 Feb; 63(2):259-64. PubMed ID: 26529980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of cystatin C- and creatinine-based estimated glomerular filtration rate equations depends on patient characteristics.
    Meeusen JW; Rule AD; Voskoboev N; Baumann NA; Lieske JC
    Clin Chem; 2015 Oct; 61(10):1265-72. PubMed ID: 26240296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examining the utility of cystatin C as a confirmatory test of chronic kidney disease across the age range in middle-aged and older community-dwelling adults.
    Canney M; Sexton DJ; O'Leary N; Healy M; Kenny RA; Little MA; O'Seaghdha CM
    J Epidemiol Community Health; 2018 Apr; 72(4):287-293. PubMed ID: 29332011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Factors Resulting Correlation and Differences in Renal Function Evaluation Index Using the Serum Cystatin C and Creatinine as Measured by an Enzymatic Method].
    Takahashi M; Takayama S; Suga H; Kadomura S; Kojima M; Iwao K; Takeda K; Sato H; Kobayashi M; Saitoh H
    Yakugaku Zasshi; 2020; 140(1):81-90. PubMed ID: 31902889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical utility of creatinine- and cystatin C-based definition of renal function for risk prediction of primary cardiovascular events in patients with diabetes.
    Schöttker B; Herder C; Müller H; Brenner H; Rothenbacher D
    Diabetes Care; 2012 Apr; 35(4):879-86. PubMed ID: 22338108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease.
    Shlipak MG; Katz R; Sarnak MJ; Fried LF; Newman AB; Stehman-Breen C; Seliger SL; Kestenbaum B; Psaty B; Tracy RP; Siscovick DS
    Ann Intern Med; 2006 Aug; 145(4):237-46. PubMed ID: 16908914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creatinine- and cystatin C-based estimated glomerular filtration rate slopes for the prediction of kidney outcome: a comparative retrospective study.
    Kim S; Hwang S; Jang HR; Sohn I; Ahn HS; Park HD; Huh W; Jin DC; Kim YG; Kim DJ; Oh HY; Lee JE
    BMC Nephrol; 2019 Jun; 20(1):214. PubMed ID: 31185945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystatin C, chronic kidney disease and retinopathy in adults without diabetes.
    Ng WY; Teo BW; Tai ES; Sethi S; Lamoureux E; Tien Yin W; Sabanayagam C
    Eur J Prev Cardiol; 2016 Sep; 23(13):1413-20. PubMed ID: 26928726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Creatinine Versus Cystatin C: Differing Estimates of Renal Function in Hospitalized Veterans Receiving Anticoagulants.
    Wang CH; Rubinsky AD; Minichiello T; Shlipak MG; Price EL
    J Gen Intern Med; 2018 Aug; 33(8):1299-1306. PubMed ID: 29855865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.